Access
to this symposium requires KEY ZONE access (paid
registration) to HDCN. For information about subscribing to HDCN,
please go to this link.
|
Peritoneal Dialysis for Children
with AKI in Nigeria: Saving Young Lives with Improvisations |
Click on image to get to talks.
 |
CKD Predictions and Concepts of
progressors and non-progressors
|
Circulating Fibroblast Growth Factor-2 (FGF-2) induces proteinuria and glomerular injury in young mice
|
Keynote Address: A Different Approach to the Dialysis Prescription |
Progression
of CKD: The role of APOL1 and other recent advances Oral
Anticoagulation in Advanced Kidney Disease |
Click on image to get to talks.
 |
Smouldering immunologic derangements in ESRD. What are
the implications?
|
Urgent-Start PD: Patient benefits
or financial incentives?
|
Is the Mediterranean diet better
than the current approach of protein restriction in pre dialysis
CKD? |
Subclinical thyroid dysfunction and clinical outcomes in end stage kidney disease |
Click on image to get to talks.
 |
Debate: Endotoxemia in CKD is primarily a fluid overload phenomenon - Yes
|
Debate: Endotoxemia in CKD is primarily a fluid overload phenomenon - No
|
Regenerative medicine - What are the prospects in nephrology? |
Keynote Address: Brain damage in pre-dialysis CKD, HD, and PD |
Click on image to get to talks.
 |
The issue of the solitary kidney
|
Recent advances in polycystic kidney disease research with emphasis on therapy |
CKD progression predictors in 2014 |
Click on image to get to talks.
 |
Epidemiology of dialysis withdrawal
|
Are the current ethical standards for dialysis withdrawal adequate? |
Lung congestion as a risk factor in end stage renal disease |
Click on image to get to talks.
 |
Stroke in Dialysis and CKD
|
Three RCTs in HDF: A critical analysis and implications for future use |
Click on image to get to talks.
 |
“Big Data” in nephrology: friend or foe?
|
Keynote Address: Non-osmotic sodium storage as a pathogenetic factor in hypertension in CKD & ESRD |
Welcome |
Click on image to get to talks.
 |
The spectrum of CKD - a patient’s journey
|
The balance between dialysis duration and sodium restriction in volume control |
Accountable Care Organizations and ESRD |
|
|